Effects of opioid dependence and tobacco use on ventilatory response to progressive hypercapnia

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 1, 2004, Pages 39-47

  Greenwald, Mark K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon dioxide; Hypercapnia; Methadone; Nicotine; Opioid dependence; Respiratory depression; Tobacco smoking; Ventilatory response

Indexed keywords

CARBON DIOXIDE; METHADONE;

ADULT; ARTICLE; BODY MASS; BREATHING RATE; CARBON DIOXIDE BLOOD LEVEL; CARBON DIOXIDE MEASUREMENT; CHRONIC DRUG ADMINISTRATION; CIGARETTE SMOKING; CONTROLLED STUDY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HUMAN; HYPERCAPNIA; HYPOXIA; LUNG MINUTE VOLUME; MALE; METHADONE TREATMENT; NORMAL HUMAN; OPIATE ADDICTION; PREDICTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY DRIVE; SAMPLE SIZE; SEX RATIO; SHORT COURSE THERAPY; TIDAL VOLUME;

NICOTIANA TABACUM;

EID: 0346655099     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.10.003     Document Type: Article

References (49)

1. Berkowitz B.A. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin. Pharmacokinet. 1:1976;219-230.
2. Bourke D.L., Warley A. The steady state and rebreathing methods compared during morphine administration in humans. J. Physiol. 419:1989;509-517.
3. Campbell B.K., Wander N., Stark M.J., Holbert T. Treating cigarette smoking in drug-abusing clients. J. Subst. Abuse Treat. 12:1995;89-94.
4. 2 and in arterial pH. Fishman A.P., Cherniack N.S., Widdicombe J.G. Handbook of physiology. vol. II:1986;475-528 American Physiological Society, Bethesda (MD).
5. Duffin J., Mohan R.M., Vasiliou P., Stephenson R., Mahamed S. A model of the chemoreflex control of breathing in humans: model parameters measurement. Respir. Physiol. 120:2000;13-26.
6. Dyer K.R., Foster D.J.R., White J.M., Somogyi A.A., Menelaou A., Bochner F. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clin. Pharmacol. Ther. 65:1999;685-694.
7. Ebenbichler M., Greenwald M.K. Past-week heroin craving reports by heroin abusers: preliminary normative data and individual differences using a novel questionnaire. Proceedings of the 64th Annual Scientific Meeting, The College on Problems of Drug Dependence. Drug Alcohol Depend., 66(Supp. 1):2002;50.
8. Eguchi K., Tadaki E., Simbulan D. Jr., Kumazawa T. Respiratory depression caused by either morphine microinjection or repetitive electrical stimulation in the region of the nucleus parabrachialis of cats. Pflugers Arch. 409:1987;367-373.
9. Elmalem E., Chorev M., Weinstock M. Antagonism of morphine-induced respiratory depression by novel anticholinesterase agents. Neuropharmacology. 30:1991;1059-1064.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis Disorders - patient edition (SCID-I/P, version 2.0). 1996;Biometrics Research Department, New York State Psychiatric Institute, New York.
11. Frosch D.L., Shoptaw S., Jarvik M.E., Rawson R.A., Ling W. Interest in smoking cessation among methadone maintained outpatients. J. Addict. Dis. 17:1998;9-19.
12. Gerak L., Butelman E.R., Woods J.H., France C.P. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 271:1994;993-999.
13. Gozal D., Ben-Ari J.H., Harper R.M., Keens T.G. Ventilatory responses to repeated short hypercapnic challenges. J. Appl. Physiol. 78:1995;1374-1381.
14. Hiltunen A.J., Lafolie P., Martel J., Ottoson E.C., Boreus L.O., Beck O.et al. Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients. Psychopharmacology. 11:1995;122-126.
15. Howell L.L. Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 273:1995;1085-1094.
16. Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory function associated with ageing. Eur. Respir. J. 13:1999;197-205.
17. Jasinski D.R., Martin W.R., Sapira J.D. Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone. Clin. Pharmacol. Ther. 9:1968;215-222.
18. Jones R.L., Neary J.M., Ryan T.G. Normal values for the hypercapnic ventilation response: effects of age and the ability to ventilate. Respiration. 60:1993;197-202.
19. Kawakami Y., Yoshikawa T., Shida A., Asanuma Y. Relationship between hypoxic and hypercapnic ventilatory responses in man. Jpn. J. Physiol. 31:1981;357-368.
20. Kawakami Y., Yamamoto H., Yoshikawa T., Shida A. Respiratory chemosensitivity in smokers: studies on monozygotic twins. Am. Rev. Respir. Dis. 126:1982;986-990.
21. Kishioka S., Paronis C.A., Lewis J.W., Woods J.H. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys. Eur. J. Pharmacol. 391:2000;289-297.
22. Laubie M., Drouilat M., Schmitt H. Discharge patterns of bulbar respiratory neurons in response to the morphinomimetic agent, fentanyl, in chloralosed dogs. Eur. J. Pharmacol. 122:1985;301-309.
23. Lewis K.W., Bosque E.M. Deficient hypoxia awakening response in infants of smoking mothers: possible relationship to sudden infant death syndrome. J. Pediatr. 127:1995;691-699.
24. Liguori A., Morse W.H., Bergman J. Respiratory effects of opioid full and partial agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 277:1996;462-472.
25. Lorinc Z., Derr J., Snider M., Lydic R. Defining origin of positive slope in hypercapnic ventilatory response curve. Am. J. Physiol. 261:1991;R747-R751.
26. Lydic R., Baghdoyan H.A., Wertz R., White D.P. Cholinergic reticular mechanisms influence state-dependent ventilatory response to hypercapnia. Am. J. Physiol. 261:1991;R738-R746.
27. Martin W.R., Jasinski D.R., Sapira J.D., Flanary H.G., Kelly O.A., Thompson A.K.et al. The respiratory effects of morphine during a cycle of dependence. J. Pharmacol. Exp. Ther. 162:1968;182-189.
28. Molho M., Faibis A., Lusky A., Shiner R.J., Ram A. Ventilatory response and pattern of breathing during hypercapnia. Bull. Eur. Physiopathol. Respir. 22:1986;21-26.
29. Navaratnam V., Foong K. Adjunctive drug use among opiate addicts. Curr. Med. Res. Opin. 11:1990;611-619.
30. Olsen G.D., Lees M.H. Ventilatory response to carbon dioxide of infants following chronic prenatal methadone exposure. J. Pediatr. 96:1980;983-989.
31. Paronis C.A., Woods J.H. Ventilation in morphine-maintained rhesus monkeys: I. Effects of naltrexone and abstinence-associated withdrawal. J. Pharmacol. Exp. Ther. 282:1997;348-354.
32. Paronis C.A., Woods J.H. Ventilation in morphine-maintained rhesus monkeys: II. Tolerance to the antinociceptive but not the ventilatory effects of morphine. J. Pharmacol. Exp. Ther. 282:1997;355-362.
33. Pianosi P., Grondin D., Desmond K., Coates A.L., Aranda J.V. Effect of caffeine on the ventilatory response to inhaled carbon dioxide. Respir. Physiol. 95:1994;311-320.
34. Read D.C. A clinical method for assessing the ventilatory response to carbon dioxide. Australas. Ann. Med. 16:1967;20-32.
35. 2 by rebreathing. Chest. 70:1976;118-121.
36. Richardson B.S., O'Grady J.P., Olsen G.D. Fetal breathing movements and the response to carbon dioxide in patients on methadone maintenance. Am. J. Obstet. Gynecol. 150:1984;400-405.
37. Santiago T.V., Pugliese A.C., Edelman N.H. Control of breathing during methadone addiction. Am. J. Med. 6:1977;347-354.
38. Santiago T.V., Goldblatt K., Winters K., Pugliese A.C., Edelman N.H. Respiratory consequences of methadone: the response to added resistance to breathing. Am. Rev. Respir. Dis. 122:1980;623-628.
39. Schalefke M.E. Central chemosensitivity: a respiratory drive. Rev. Physiol. Biochem. Pharmacol. 90:1981;171-210.
40. Shipley B. The Shipley Institute of Living Scale. 1967;Western Psychological Services, Los Angeles.
41. 2 matter? Chest. 117:2000;454-459.
42. Stark M.J., Campbell B.K. Drug use and cigarette smoking in applicants for drug abuse treatment. J. Subst. Abuse. 5:1993;175-181.
43. Takeda S., Eriksson L.I., Yamamoto Y., Joensen H., Onimaru H., Lindahl S.G. Opioid action on respiratory neuron activity of the isolated respiratory network in newborn rats. Anesthesiology. 95:2001;740-749.
44. Torrens M., Castillo C., San L., del Morral E., Gonzalez M.L., de la Torre R. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug Alcohol Depend. 52:1998;193-200.
45. Warner-Smith M., Darke S., Lynskey M., Hall W. Heroin overdose: causes and consequences. Addiction. 96:2001;1113-1125.
46. Weinstock M., Roll D., Erez E., Bahar M. Physostigmine antagonizes morphine induced respiratory depression but not analgesia in dogs and rabbits. Br. J. Anaesth. 52:1980;1171-1176.
47. White J.M., Irvine R.J. Mechanisms of fatal opioid overdose. Addiction. 94:1999;961-972.
48. Willette R.N., Doorley B.M., Sapru H.N. Activation of cholinergic mechanisms in the medulla oblongata reverses intravenous opioid-induced respiratory depression. J. Pharmacol. Exp. Ther. 240:1987;352-358.
49. Yamamoto H., Inaba S., Nishiura Y., Kishi F., Kawakami Y. Acute inhalation of cigarette smoke augments hypoxic chemosensitivity in humans. J. Appl. Physiol. 58:1985;717-723.